SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* SOON SHIONG PATRICK (Last) (First) (Middle) C/O ABRAXIS BIOSCIENCE, INC. 11755 WILSHIRE BLVD., 20TH FLOOR (Street) LOS ANGELES CA 90025 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Abraxis BioScience, Inc. [ ABBI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner X Officer (give title below) Other (specify below) Chairman and CEO
	3. Date of Earliest Transaction (Month/Day/Year) 01/12/2007
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/12/2007		J(1)		282,986	D	(1)	3,286,611	I	By RSU Plan LLC(4)
Common Stock	04/20/2007		J(2)		106,119	D	(2)	3,158,628	I	By RSU Plan LLC(4)
Common Stock	10/26/2007		J(3)		19,258	D	(3)	3,139,370	I	By RSU Plan LLC(4)
Common Stock	10/26/2007		J(3)		631,015	D	(3)	115,616,590	I	By Family Trusts(5)
Common Stock	10/26/2007		J(3)		68,748	D	(3)	12,586,061	I	By GRATs(6)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Contribution to the issuer of shares in connection with vesting of certain restricted units held by an employee or consultant of the issuer. The closing price on the date of contribution was $26.79.

2. Contribution to the issuer of shares in connection with vesting of certain restricted units held by an employee or consultant of the issuer. The closing price on the date of contribution was $27.67.

3. Surrender of shares pursuant to an escrow agreement entered into April 18, 2006 in connection with merger of American BioScience Inc. with and into the issuer (the "Merger"). The shares were surrendered in satisfaction of claims arising from the indemnification obligation set forth in the merger agreement. The closing price on the date of surrender was $24.27.

4. LLC has agreed to contribute to the issuer from time to time, in connection with vesting of certain restricted units held by certain employees of the issuer, up to the total number of shares held by LLC (or, at the election of the LLC, cash in an amount equal to the value of the shares otherwise required to be contributed by the LLC). The Reporting Person disclaims beneficial ownership of the shares held by the LLC except to the extent of his pecuniary interest in the LLC.

5. Includes shares acquired by the family trusts for the benefit of members of the Reporting Person's immediate family. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

6. Includes shares acquired by the GRATS for the benefit of members for the benefit of members of the Reporting Person's immediate family. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

	/s/ Richard Maroun, power of attorney	10/30/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.